Merck Announces First-Quarter 2023 Financial Results

First Quarter 2023 Reflected Continued Strong Underlying Performance Across Key Growth Drivers, Particularly in Oncology and Vaccines



Total Worldwide Sales Were $14.5 Billion, a Decrease of 9%... | April 27, 2023

Related Keywords

United States ,Chicago ,Illinois ,Canada ,Japan ,Australia ,China ,Canadian ,American ,Adempas Verquvo ,Robertm Davis ,Gardasil ,Twitter ,Merck Co Inc ,World Health Organization Group ,Oncology Program ,Gilead Sciences ,Sichuan Kelun Pharmaceutical Co Ltd ,Youtube ,Net Income Attributable To Merck Co Inc ,Cardiovascular Program ,Facebook ,Exchange Commission ,Drug Administration ,American Association For Cancer Research Annual Meeting ,American College Of Cardiology ,Linkedin ,Imago Biosciences Inc ,World Heart Federation Congress ,European Medicines Agency ,Merck Co ,Oncologic Drugs Advisory Committee On ,Infectious Diseases Program ,Instagram ,Moderna Inc ,Canadian Cancer Trials Group ,Animal Health ,European Society For Medical Oncology Virtual Plenary ,Statement Of Merck Co Inc ,Alliance Revenue ,Prometheus Biosciences Inc ,Animal Health Revenue ,Most Sustainable Us Companies ,Accepted Accounting Principles ,Imago Biosciences ,Prometheus Biosciences Strengthens Immunology ,Prometheus Biosciences ,American College ,Annual Scientific Session ,World Heart Federation ,World Congress ,New England Journal ,Biologics License Application ,Prescription Drug User Fee Act ,American Association ,Cancer Research Annual ,Breakthrough Therapy Designation ,Priority Medicines ,European Medicines ,Gynecologic Oncology Annual Meeting ,European Society ,Medical Oncology Virtual ,Cancer Trials Group ,Oncologic Drugs Advisory Committee ,New Drug Application ,Oncology Investor Event ,American Society ,Clinical Oncology Annual Meeting ,Human Papillomavirus Quadrivalent ,Human Papillomavirus ,Conjugate Vaccine ,Rotavirus Vaccine ,Live Oral ,Quarter Expense ,Loss From Investments ,Tax Cuts ,Jobs Act ,Net Income Due ,Excluded Items ,Canada Toll Free ,Looking Statement ,Securities Litigation Reform Act ,Annual Report ,Net Income ,Income Attributable ,Common Share Assuming ,Divestiture Related Costs ,Tax Provision ,Total Vaccines ,Total Diabetes ,Includes Pharmaceutical ,Nc Stock Exchange ,News ,Information ,Press Release ,First ,Quarter ,023 ,Deflected ,Ontinued ,Strong ,Underlying ,Performance ,Cross ,Key ,Growth ,Particularly ,N ,Ncology ,End ,Orldwide ,Sales ,Were ,Decrease ,F Mrk Us58933y1055 ,